{"name":"VSM Geneesmiddelen b.v.","slug":"vsm-geneesmiddelen-b-v","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Ginkgo biloba extract EGb 761","genericName":"Ginkgo biloba extract EGb 761","slug":"ginkgo-biloba-extract-egb-761","indication":"Cognitive impairment in dementia","status":"phase_2"}]}],"pipeline":[{"name":"Ginkgo biloba extract EGb 761","genericName":"Ginkgo biloba extract EGb 761","slug":"ginkgo-biloba-extract-egb-761","phase":"phase_2","mechanism":"Ginkgo biloba extract EGb 761 is believed to improve blood flow to the brain by increasing nitric oxide production and reducing platelet aggregation.","indications":["Cognitive impairment in dementia","Alzheimer's disease"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}